Moleculin Biotech, Inc.·4

Jun 18, 9:01 PM ET

Foster Jonathan P. 4

4 · Moleculin Biotech, Inc. · Filed Jun 18, 2025

Insider Transaction Report

Form 4
Period: 2025-06-16
Transactions
  • Tax Payment

    Common Stock

    2025-06-16$0.69/sh203$13911,993 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-06-16833230,684 total
    Common Stock (833 underlying)
  • Exercise/Conversion

    Common Stock

    2025-06-16+83312,196 total
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
  • [F3]On June 16, 2021, the reporting person was granted 3,334 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4